Page last updated: 2024-08-23

nitrosobis(2-oxopropyl)amine and Disease Exacerbation

nitrosobis(2-oxopropyl)amine has been researched along with Disease Exacerbation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Grandhi, BK; Prabhu, S; Thakkar, A; Wang, J1
Furukawa, F; Hirose, M; Kanki, K; Kawamori, T; Lee, IS; Nishikawa, A; Okazaki, K; Umemura, T; Wakabayashi, K1

Other Studies

2 other study(ies) available for nitrosobis(2-oxopropyl)amine and Disease Exacerbation

ArticleYear
A novel combinatorial nanotechnology-based oral chemopreventive regimen demonstrates significant suppression of pancreatic cancer neoplastic lesions.
    Cancer prevention research (Philadelphia, Pa.), 2013, Volume: 6, Issue:10

    Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Aspirin; Carcinogens; Cell Line, Tumor; Cricetinae; Curcumin; Disease Models, Animal; Disease Progression; Drug Delivery Systems; Immunohistochemistry; In Situ Nick-End Labeling; Isothiocyanates; Lipids; Male; Mesocricetus; Nanoparticles; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Sulfoxides

2013
A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters.
    International journal of cancer, 2003, Apr-10, Volume: 104, Issue:3

    Topics: Adenocarcinoma; Animals; Cell Transformation, Neoplastic; Cricetinae; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Disease Progression; Isoenzymes; Male; Mesocricetus; Nitrosamines; Pancreatic Neoplasms; Proliferating Cell Nuclear Antigen; Prostaglandin-Endoperoxide Synthases; Sulfonamides

2003